Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Grace Therapeutics, Inc. (GRCE) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$0.64M |
|
-- |
|
-- |
|
$3.18M |
|
$-3.18M |
|
$2.80M |
|
$-0.38M |
|
$-0.38M |
|
$0.64M |
|
$0.64M |
|
$0.64M |
|
$0.64M |
|
$-3.18M |
|
$-3.18M |
|
12.09M |
|
12.09M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$22.71M |
|
$0.01M |
|
$49.28M |
|
$71.99M |
|
$1.93M |
|
-- |
|
$3.45M |
|
$5.38M |
|
$66.61M |
|
$17.34M |
|
$66.61M |
|
13.72M |
|
| Cash Flow Statement Financials | |
$-14.90M |
|
-- |
|
$14.03M |
|
$23.00M |
|
$22.13M |
|
$-0.87M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.77 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.95% |
|
3.67% |
|
0.88% |
|
0.95% |
|
$4.86 |
|
$-1.23 |
|
$-1.23 |
|